Royalty Security, LLC

18 patents currently held · Updated Nov 14, 2026

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

Dec 2027

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Dec 11, 2026
The maintenance fee for Methods of Use of Cyclopamine Analogs (US 10,314,827) comes due Dec 11, 2026. Unpaid by Jun 11, 2027, it lapses early.
2 fees due Mar 10 to 29, 2027 · next Mar 10

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Patent	Title	Status	Expires	Confidence
US 8,227,509	Methods of use of cyclopamine analogs In force Term ends Dec 27, 2027 · From the USPTO record	In force	Term ends Dec 27, 2027	From the USPTO record
US 8,895,576	Methods of Use of Cyclopamine Analogs In force Term ends Dec 27, 2027 · High confidence	In force	Term ends Dec 27, 2027	High confidence
US 9,145,422	Methods of Use of Cyclopamine Analogs In force Term ends Dec 27, 2027 · High confidence	In force	Term ends Dec 27, 2027	High confidence
US 9,238,672	Methods for stereoselective reduction In force Term ends Dec 27, 2027 · From the USPTO record	In force	Term ends Dec 27, 2027	From the USPTO record
US 9,492,435	Cyclopamine analogs In force Ends no later than Dec 27, 2027 · From the USPTO record	In force	Ends no later than Dec 27, 2027	From the USPTO record
US 9,669,011	Methods of Use of Cyclopamine Analogs In force Term ends Dec 27, 2027 · High confidence	In force	Term ends Dec 27, 2027	High confidence
US 9,951,083	Cyclopamine analogs In force Ends no later than Dec 27, 2027 · From the USPTO record	In force	Ends no later than Dec 27, 2027	From the USPTO record
US 10,314,827	Methods of Use of Cyclopamine Analogs In force Term ends Dec 27, 2027 · High confidence	In force	Term ends Dec 27, 2027	High confidence
US 10,406,139	Cyclopamine analogs In force Ends no later than Dec 27, 2027 · From the USPTO record	In force	Ends no later than Dec 27, 2027	From the USPTO record
US 11,007,181	Cyclopamine analogs In force Ends no later than Dec 27, 2027 · From the USPTO record	In force	Ends no later than Dec 27, 2027	From the USPTO record

10 of 18 patents shown.

Pro members see all 18.

Pro members: see all 18 patents

Also on record, not counted in the 18: 9 lapsed for an unpaid fee · 3 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro